Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Lymphatic Research and Biology|October 4, 2018
Normative Interlimb Impedance Ratios: Implications for Early Diagnosis of Uni- and Bilateral, Upper and Lower Limb LymphedemaMegan L Steele, Monika Janda, Dimitrios Vagenas, et al.
Lymphatic Research and Biology|September 6, 2019
A Bioimpedance Spectroscopy-Based Method for Diagnosis of Lower-Limb LymphedemaMegan L Steele, Monika Janda, Dimitrios Vagenas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 9, 2020
Improving response to progestin treatment of low-grade endometrial cancerEva Baxter, Donal J Brennan, Jessica N McAlpine, et al.
Gynecologic Oncology|August 21, 2017
Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counsellingSharon E Johnatty, Yen Y Tan, Daniel D Buchanan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2011
Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITOPhilipp Harter, Jalid Sehouli, Alexander Reuss, et al.
Surgical Endoscopy|April 8, 2020
Development and validation of a recommended checklist for assessment of surgical videos quality: the LAParoscopic surgery Video Educational GuidelineS (LAP-VEGaS) video assessment toolValerio Celentano, Neil Smart, Ronan A Cahill, et al.
The New England Journal of Medicine|November 1, 2018
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical CancerPedro T Ramirez, Michael Frumovitz, Rene Pareja, et al.
BMJ Open|January 18, 2024
Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocolSandra C Hayes, Rosalind R Spence, Monika Janda, et al.
The Lancet. Oncology|June 6, 2020
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trialMichael Frumovitz, Andreas Obermair, Robert L Coleman, et al.
BMJ Open|April 13, 2023
Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trialSandra Hayes, Andreas Obermair, Linda Mileshkin, et al.
Pageof 18